People · Operator
Named in public records as an officer, director or promoter · active 2013–2015 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neurodyn Life Sciences Inc. | — | Biotechnology | Seed | $5.2M | $28.9M | 2013 |
Denis G. Kay at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Denis G. Kay on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kenneth A. Cawkell | 1 | 3 |
| Denis A. Kay | 1 | 2 |
| Robert L. Cervelli | 1 | 1 |
| Richard L. Devries | 1 | 1 |
| Robert A. Cervelli | 1 | 1 |
| Scott A. Homenick | 1 | 1 |
| James A. Mertz | 1 | 1 |
| Alfred L. Maelicke | 1 | 1 |
| James L. Mertz | 1 | 1 |
| Len L. Mertz | 1 | 1 |
| Madolyn L. Mertz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.